Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...

Roche’s CD20xCD3 bispecific antibody Columvi has improved survival when used as a second-line therapy for diffuse large B-cell lymphoma (DLBCL) in a phase 3 trial, setting up regulatory filings for ...

Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...

U.S. destroys 16 Iranian naval vessels in Strait of Hormuz to prevent mine-laying, as conflict widens and oil prices surge toward $120.

Tonight will see areas of cloud, clear breaks and a few light showers push in from the southwest. In the early hours, it will turn overcast and mainly dry. Sunday Tomorrow will turn mild. It will be a ...

Acurx Pharmaceuticals, Inc.  ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today announced ...

A tour of the unsung vehicles that keep a United States Navy ship running: spotting dollies, tow tractors, “Tilly” cranes, forklifts, P-25 fire trucks, RHIBs, LCAC hovercraft, AAVs, and SEAL Delivery ...

Craftsman's 26-piece ratcheting multi-bit screwdriver set is one of the best out there, and this Amazon discount means it's a ...

Vertex Pharmaceuticals (NASDAQ:VRTX) shares rose 6% to $488.52 in premarket trading Thursday after the company reported successful results from a late-stage trial ...

Acurx's Program in the Broader CDI Patient Population is Ready to Advance toPhase 3 International Clinical Trials Acurx is launching a ground-breaking clinical trial ...

Vertex Pharmaceuticals (NASDAQ:VRTX) shares climbed about 6% to $488.52 in premarket trading Thursday after the company reported encouraging results from a late-stage clinical trial of its kidney ...